IHL - Incannex - SIG Venture Capital, page-14

No problem.

My point is - optics is everything... What is undeniable today, from reading everyone's posts on this forum, is that many shareholders are not pleased with the optics around this CR;

- Timing (raising at a discount, to 52w lows)
- Price & options
- Trust in management (saying we are well funded, in an enviable position, then boom - dilution)
- Short positions increasing significantly from September (right about the time IHL were apparently approached)
- Disclosing of sensitive information to certain shareholders, but not the market (could the same have been done earlier, leading to the increase in shorts?)

Back to my main point - My question to you would be; could the institution involved in the capital raise, bring more or less value to the company, depending on who it was??

e.g. If it was a big pharma, such as Pfizer - would you perceive that as being better value, than let's say, Roth Capital?

Of course it would. Which is exactly why you are dissecting information about the above company and what value they could bring / justify the cheap shares they have been given.

But, fact is, this is not public information yet.

I'm happy that tossydog shared it with us, but, at the same time - it is still a big concern if management are leaking information to shareholders that they aren't giving the general public.